Panacea Biotec Limited

₹355.95As of Sun 8 Nov 2026, 12:00 UTC
NSE:PANACEABIOHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 12.35%
Div yield —
ROE (0.86%)
Biotechnology
Beta (5Y) 0.34
PE TTM —
TSR TTM (18.71%)
Mkt cap ₹21.80B
ROIC (3.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹435
22.18%
191.34%
Hold 5|2|8|9|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
4.30
4.63
4.48
4.32
10.55%
25.16%
10.87%
11.04%
Revenue₹B
2.680
2.832
2.750
2.727
8.32%
14.40%
6.07%
4.50%
Peers (US$224.3M)
Cap (US$)
PE
117.9M
19.70x
Capital
TTM
5Y
10Y
Leveragex
0.896
0.023
0.018
EBIT/Intx
0.285
0.140
0.140
Own earn%
347.16
63.74
55.65
Sh yield%
35.38
30.02
28.11
Owners
Insiders/Inst%
0.12
34.76
Short interest%
2.98
SBC / revenue%
0.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
0–3
$1 testx
1.2
Incr. ROIC%
7